Acute Effects of Pimobendan on Cardiac Function in Dogs With Tachycardia Induced Dilated Cardiomyopathy: A Randomized, Placebo-Controlled, Crossover Study
Background: Pimobendan provides a significant survival benefit in dogs with cardiac disease, including degenerative mitral valve disease and dilated cardiomyopathy (DCM). Its positive inotropic effect is well-known, however, it has complex effects and the mechanisms behind the survival benefit are n...
Main Authors: | Kaitlin Abbott-Johnson, Kursten V. Pierce, Steve Roof, Carlos L. del Rio, Robert Hamlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2021.646437/full |
Similar Items
-
Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation
by: Pakit Boonpala, et al.
Published: (2023-08-01) -
Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs
by: Prapawadee Pirintr, et al.
Published: (2023-10-01) -
Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs
by: Jiwoong Her, et al.
Published: (2020-08-01) -
Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial
by: Nayeli Iwanuk, et al.
Published: (2019-07-01) -
The effect of pimobendan and enalapril use on blood serum trace element levels in dogs with myxomatous mitral valve disease
by: Bengü Bilgiç, et al.
Published: (2023-06-01)